Home › HSCL › Filing
🔔 Get instant alerts when HSCL files quarterly results on BSE Start free trial →

Analysts/Institutional Investor Meet/Con. Call Updates

Filed: 28 Oct 2026, 18:26 IST Exchange: NSE Category: Financial Results — Earnings Call Transcript
AI summary - Q2 FY27 standalone revenue 1,543cr +44% y-y; EBITDA 308cr +27% y-y; PAT 240cr +28% y-y - Consolidated Q2 revenue 1,691cr +58% y-y; EBITDA 303cr +27% y-y; PAT 231cr +31% y-y - Carbon Nanotube facility commissioning targeted Q4 FY27; LFP 2,000 TPA plant Q3 FY27 - Birla Tyres merger proposed; business on track to breakeven - Mining operations to start this quarter after environmental clearance - EBITDA per metric ton expected 20,000-24,000 INR range; margins resilient to raw material price swings - Capex spend INR 800-900cr in FY27; full impact of new capacities from FY29 - Working capital improving; focus on internal accrual funding for capex
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 HSCL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add HSCL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Himadri Speciality Chemical Limited

Important. The summary above is generated automatically from Himadri Speciality Chemical Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.